1,758 companies
Allergan plc
Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a global pharmaceutical leader focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world.
Ireland
ALTH
Allos Therapeutics Inc
Colorado
Inactive
NASDAQ
ALNY
Alnylam Pharmaceuticals Inc
alnylam is developing an entirely new class of innovative medicines based on a breakthrough discovery in biology known as rna interference, or rnai.
Massachusetts
NASDAQ
Alpha Beta Technology Inc
Massachusetts
Inactive
Alpharma Inc
Alio Gold, Inc.
New Jersey
Inactive
ALPN
Alpine Immune Sciences Inc
founded in 2015 by a team responsible for the fda's approval of the world's first cancer immunotherapy and experts in the field of recombinant protein based immunotherapies, alpine immune sciences was created to capitalize on our unique understanding of immunology, modifying the complexities of the immune synapse for the benefit of patients living with cancer, autoimmune disorders, and other diseases.
Washington
NASDAQ
Alseres Pharmaceuticals, Inc.
We are a biotechnology company focused on diagnostic products primarily for disorders in the central nervous system, or CNS. Our clinical product candidate is called Altropane and is a molecular imaging program focused on the diagnosis of i) Parkinsonian Syndromes, or PS including Parkinson’s Disease, or PD, and ii) Dementia with Lewy Bodies, or DLB; At December 31, 2013, we were considered a “development stage enterprise” and will continue to be so until the commencement of commercial operations.
Massachusetts
Inactive
CYTO
Altamira Therapeutics Ltd
altamira therapeutics (former auris medical) is dedicated to developing therapeutics that address important unmet medical needs.
Bermuda
NASDAQ
Altana Aktiengesellschaft
Inactive
Altarex Corp
Alberta, Canada
Inactive
ATHE
Alterity Therapeutics Ltd
alterity therapeutics limited researches and develops therapeutic drugs for the treatment of parkinsonian's disease and other neurodegenerative diseases in australia.
Australia
NASDAQ
ALT
Altimmune Inc
altimmune, inc.
Maryland
NASDAQ
ANRO
Alto Neuroscience Inc.
California
NYSE
ALXO
Alx Oncology Holdings Inc
alx oncology (previously alexo therapeutics) is a clinical-stage immuno-oncology company developing therapies that block the cd47 myeloid checkpoint mechanism exploited by cancer cells to evade the immune system.
California
NASDAQ
Alza TTS Research Partners LTD
California
Inactive
ALZN
Alzamend Neuro Inc
alzamend neuro is a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of alzheimer’s disease, bipolar disorder, major depressive disorder (“mdd”) and post-traumatic stress disorder (“ptsd”). our mission is to rapidly develop and market safe and effective treatments to bring aid to the 43+ million americans suffering from these debilitating diseases.
Georgia
NASDAQ
Alzheon, Inc.
Massachusetts
AMAG
Amag Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc.
Massachusetts
NASDAQ
AMBS
Amarantus Bioscience Holdings, Inc.
Amarantus BioScience Holdings, Inc.
California
OTC
AMRN
Amarin Corp
amarin corporation plc is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health.
Ireland
NASDAQ